22.04.2026 • Topics

Biological Control Instead of Biocides: How Cooling Water Systems Can be Operated More Efficiently

© Blue Activity

Author: Lars Havighorst, Blue Activity

Cooling water systems influence energy requirements, system availability and compliance. Biofilms reduce heat transfer and significantly increase OPEX. Biological control concepts, supported by the updated VDI 2047 Sheet 2 and stricter environmental requirements, enable stable processes without conventional biocides and improve efficiency as well as water and energy balance.

Cooling water systems are the backbone of industrial heat dissipation. But while companies invest millions in process optimization, cooling water often remains an invisible cost centre. Just 1 mm of biofilm build-up on heat exchanger surfaces can reduce heat transfer by 10 - 40 % - in typical systems this means additional costs of EUR 100,000 - 800,000 per year.
The standard answer for decades has been: more chemicals. But conventional biocides take a "kill" approach, which inevitably generates selective pressure, resistance formation and wastewater pollution:

  • Resistance formation: Microorganisms adapt, dosing rates increase, efficacy decreases.
  • AOX pollution: Biocides containing chlorine and bromine generate AOX concentrations that reach up to 1.5 mg/L - and thus exceed the possible future limit value of 0.3 mg/L (trend until 2030) many times over.
  • Hidden costs: Contaminated heat exchangers increase condensation temperatures and energy consumption. Added to this are heavy polluter surcharges and rising wastewater levies.

Continue with login

No account yet?

Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.

Register

Company

Logo:

blue activity GmbH

Rudolf-Diesel-Str. 11
69115 Heidelberg
Germany

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read